The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners....
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
The National Police Chiefs' Council has approved the first official guidance for medical cannabis.
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains,...
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing...
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an...
